Kaplan & Sadock’s Concise Textbook of Clinical Psychiatry 5th Edition by Robert Boland, ISBN-13: 978-1975167486

Description

Trustpilot

Kaplan & Sadock’s Concise Textbook of Clinical Psychiatry 5th Edition by Robert Boland, ISBN-13: 978-1975167486

[PDF eBook eTextbook] – Available Instantly

• Publisher: ‎ LWW; Fifth edition (March 22, 2022)
• Language: ‎ English
• ISBN-10: ‎ 1975167481
• ISBN-13: ‎ 978-1975167486

Succinct, authoritative, and affordable, Kaplan & Sadock’s Concise Textbook of Psychiatry, 5th Edition, provides must-know information in clinical psychiatry from the names you trust. From cover to cover, it contains the most relevant clinical material from the bestselling Kaplan and Sadock’s Synopsis of Psychiatry 12th Edition, including the foundational chapters on assessment, the disorder specific chapters, and all of the treatment-specific chapters among other essential topics such as emergency psychiatry, ethics, and palliative/end-of-life care. New editors Robert Boland and Marcia L. Verduin, along with consulting editor Pedro Ruiz, have updated all content with a focus on reformatting and summarizing for faster access to key information.

– Provides concise but thorough coverage of the entire field of clinical psychiatry, including biologic, psychologic, and sociologic factors in health and disease.

– Offers step-by-step guidance on the clinical examination, the psychiatric report, medical assessment of the psychiatric patient, laboratory tests, and signs and symptoms, as well as all psychiatric and substance-related disorders, with special chapters on children, adolescents, and the elderly.

– Presents the most current treatment methods including descriptions of all modern psychotherapeutic techniques.

– Contains real-world case histories throughout and features a unique glossary of psychiatric signs and symptoms.

– Includes thorough updates and revisions throughout, all consistent with the DSM-5.

– Presents a comprehensive overview of the clinical aspects of psychiatry for clinicians, residents, students, and all others who provide mental health care.

Table of Contents:

Cover

Title Page

Copyright

Dedication

Preface

Contents

About the Authors

A Clinical Psychiatry

1. Examination and Diagnosis of the Psychiatric Patient

1.1 The Adult Patient

PSYCHIATRIC INTERVIEW, HISTORY, AND MENTAL STATUS EXAMINATION

PHYSICAL EXAMINATION OF THE PSYCHIATRIC PATIENT

THE PSYCHIATRIC REPORT AND MEDICAL RECORD

PSYCHIATRIC RATING SCALES

CLINICAL NEUROPSYCHOLOGY AND INTELLECTUAL ASSESSMENT OF ADULTS

PERSONALITY ASSESSMENT: ADULTS AND CHILDREN

MEDICAL ASSESSMENT AND LABORATORY TESTING IN PSYCHIATRY

NEUROIMAGING

1.2 Children and Adolescents

CLINICAL INTERVIEWS

DIAGNOSTIC INSTRUMENTS

QUESTIONNAIRES AND RATING SCALES

COMPONENTS OF THE CHILD PSYCHIATRIC EVALUATION

INTELLECTUAL DISABILITY PSYCHIATRIC INTERVIEW AND TESTS

1.3 Geriatric Patients

PSYCHIATRIC EXAMINATION OF THE OLDER PATIENT

EARLY DETECTION AND PREVENTION STRATEGIES

2. Neurodevelopmental Disorders and Other Childhood Disorders

2.1 Intellectual Disability

NOMENCLATURE

CLASSIFICATION

DEGREES OF SEVERITY OF INTELLECTUAL DISABILITY

CLINICAL FEATURES

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

2.2 Communication Disorders

LANGUAGE DISORDER

SPEECH SOUND DISORDER

CHILD-ONSET FLUENCY DISORDER (STUTTERING)

SOCIAL (PRAGMATIC) COMMUNICATION DISORDER

UNSPECIFIED COMMUNICATION DISORDER

2.3 Autism Spectrum Disorder

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY AND PATHOGENESIS

2.4 Attention-Deficit/Hyperactivity Disorder

CLINICAL FEATURES

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

ADULT MANIFESTATIONS OF ADHD

2.5 Specific Learning Disorder

SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN READING

SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN MATHEMATICS

SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN WRITTEN EXPRESSION

2.6 Motor Disorders

DEVELOPMENTAL COORDINATION DISORDER

STEREOTYPIC MOVEMENT DISORDER

TOURETTES DISORDER

PERSISTENT (CHRONIC) MOTOR OR VOCAL TIC DISORDER

2.7 Feeding and Eating Disorders of Infancy or Early Childhood

PICA

RUMINATION DISORDER

AVOIDANT/RESTRICTIVE FOOD INTAKE DISORDER

2.8 Trauma- and Stressor-Related Disorders in Children

REACTIVE ATTACHMENT DISORDER AND DISINHIBITED SOCIAL ENGAGEMENT DISORDER

POSTTRAUMATIC STRESS DISORDER OF INFANCY, CHILDHOOD, AND ADOLESCENCE

2.9 Depressive Disorders and Suicide in Children and Adolescents

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

SUICIDE

2.10 Early-Onset Bipolar Disorder

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

2.11 Disruptive Mood Dysregulation Disorder

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

2.12 Disruptive Behaviors of Childhood

OPPOSITIONAL DEFIANT DISORDER

CONDUCT DISORDER

2.13 Anxiety Disorders of Infancy, Childhood, and Adolescence: Separation Anxiety Disorder, Generalized Anxiety Disorder, and Social Anxiety Disorder (Social Phobia)

SEPARATION ANXIETY DISORDER

GENERALIZED ANXIETY DISORDER

SOCIAL ANXIETY DISORDER (SOCIAL PHOBIA)

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

2.14 Selective Mutism

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

2.15 Obsessive-Compulsive Disorder in Childhood and Adolescence

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

2.16 Early-Onset Schizophrenia

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

ATTENUATED PSYCHOSIS SYNDROME

2.17 Adolescent Substance Use Disorders

DIAGNOSIS AND CLINICAL FEATURES

COMORBIDITY

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

3. Neurocognitive Disorders

DEFINITION

CLINICAL EVALUATION

PATHOLOGY AND LABORATORY EXAMINATION

3.1 Delirium

DIAGNOSIS AND CLINICAL FEATURES

PHYSICAL AND LABORATORY EXAMINATIONS

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

3.2 Dementia (Major Neurocognitive Disorder)

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

3.3 Major or Minor Neurocognitive Disorder due to Another Medical Condition (Amnestic Disorders)

DIAGNOSIS

CLINICAL FEATURES AND SUBTYPES

PATHOLOGY AND LABORATORY EXAMINATION

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

3.4 Neurocognitive and Other Psychiatric Disorders due to a General Medical Condition

SPECIFIC DISORDERS

3.5 Mild Cognitive Impairment

DEFINITION

CLINICAL PRESENTATION

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY AND ETIOLOGY OF MCI

4. Substance Use and Addictive Disorders

4.1 General Features of the Substance-Related Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

COMORBIDITY

TREATMENT APPROACH

ETIOLOGY

4.2 Alcohol-Related Disorders

DIAGNOSIS AND CLINICAL FEATURES

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT OF ALCOHOL USE DISORDERS

PATHOLOGY

ETIOLOGY

4.3 Cannabis-Related Disorders

CLINICAL FEATURES

DIAGNOSIS

COMORBIDITY

TREATMENT AND REHABILITATION

EPIDEMIOLOGY

PATHOLOGY

4.4 Opioid-Related Disorders

CLINICAL FEATURES

COMORBIDITY

TREATMENT AND REHABILITATION

EPIDEMIOLOGY

PATHOLOGY

ETIOLOGY

4.5 Sedative-, Hypnotic-, or Anxiolytic-Related Disorders

DIAGNOSIS

TREATMENT AND REHABILITATION

EPIDEMIOLOGY

PATHOLOGY

4.6 Stimulant-Related Disorders

CLINICAL FEATURES

DIAGNOSIS

COMORBIDITY

TREATMENT AND REHABILITATION

EPIDEMIOLOGY

PATHOLOGY

ETIOLOGY

4.7 Tobacco-Related Disorders

CLINICAL FEATURES

DIAGNOSIS

TREATMENT

EPIDEMIOLOGY

PATHOLOGY

4.8 Caffeine-Related Disorders

CLINICAL FEATURES AND DIAGNOSIS

COMORBIDITY

TREATMENT

EPIDEMIOLOGY

PATHOLOGY AND ETIOLOGY

4.9 Hallucinogen-Related Disorders

CLINICAL FEATURES

DIAGNOSIS

TREATMENT

EPIDEMIOLOGY

PATHOLOGY

4.10 Inhalant-Related Disorders

CLINICAL FEATURES

DIAGNOSIS

TREATMENT

EPIDEMIOLOGY

4.11 Anabolic-Androgenic Steroid Use

CLINICAL FEATURES AND DIAGNOSIS

TREATMENT

EPIDEMIOLOGY

PATHOLOGY

ETIOLOGY

4.12 Gambling Disorder

CLINICAL FEATURES

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

4.13 Other Disorders Related to the Addictive Disorders

INTERNET GAMING DISORDER

MOBILE OR CELL PHONE COMPULSION

REPETITIVE SELF-MUTILATION

COMPULSIVE SEXUAL BEHAVIOR

5. Schizophrenia Spectrum and Other Psychotic Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

OBJECTIVE TESTS FOR THE DISORDER

DIFFERENTIAL DIAGNOSIS FOR PSYCHOTIC DISORDERS

COMORBIDITY

COURSE

PROGNOSIS

TREATMENT APPROACH

THE EPIDEMIOLOGY OF THE DISORDERS

THE NEUROBIOLOGY OF THE DISORDER

THE PSYCHOLOGY OF THE DISORDER

ETIOLOGY

6. Bipolar Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE

PROGNOSIS

TREATMENT APPROACH

THE EPIDEMIOLOGY OF THE DISORDER(S)

THE NEUROBIOLOGY OF THE DISORDER

THE PSYCHOLOGY OF THE DISORDER

ETIOLOGY

7. Depressive Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE

PROGNOSIS

TREATMENT APPROACH

THE EPIDEMIOLOGY OF DEPRESSION

THE NEUROBIOLOGY OF DEPRESSION

THE PSYCHOLOGY OF DEPRESSION

ETIOLOGY

8. Anxiety Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE

TREATMENT APPROACH

THE EPIDEMIOLOGY OF THE DISORDER(S)

THE NEUROBIOLOGY OF THE DISORDER

ETIOLOGY

9. Obsessive-Compulsive and Related Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

10. Trauma- and Stressor-Related Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS FOR THE TRAUMA- AND STRESSOR-RELATED DISORDERS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT APPROACH

EPIDEMIOLOGY

ETIOLOGY

11. Dissociative Disorders

DIAGNOSTIC AND CLINICAL FEATURES

DEPERSONALIZATION/DEREALIZATION DISORDER

DISSOCIATIVE IDENTITY DISORDER

OTHER SPECIFIED OR UNSPECIFIED DISSOCIATIVE DISORDER

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

12. Somatic Symptom and Related Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

EVALUATION OF SOMATIC SYMPTOM AND RELATED DISORDERS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT OF SOMATIC SYMPTOM AND RELATED DISORDERS

EPIDEMIOLOGY

ETIOLOGY

13. Feeding and Eating Disorders

CLINICAL FEATURES

DIAGNOSIS AND CLINICAL FEATURES

PATHOLOGY AND LABORATORY EXAMINATION

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT APPROACH

EPIDEMIOLOGY

ETIOLOGY

14. Elimination Disorders

ENCOPRESIS

ENURESIS

15. Sleep–Wake Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

CLINICAL TOOLS IN SLEEP MEDICINE

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

TREATMENT APPROACH

16. Human Sexuality and Sexual Dysfunctions

SEXUAL DYSFUNCTIONS

PARAPHILIC DISORDERS

SEX ADDICTION AND COMPULSIVITY

NORMAL SEXUALITY

17. Gender Dysphoria, Gender Identity, and Related Conditions

INTRODUCTION

DIAGNOSIS AND CLINICAL FEATURES

DIFFERENTIAL DIAGNOSIS

COURSE AND PROGNOSIS

COMORBIDITY

TREATMENT

EPIDEMIOLOGY

ETIOLOGY

18. Disruptive, Impulse-Control, and Conduct Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

OBJECTIVE TESTS FOR THE DISORDERS

DIFFERENTIAL DIAGNOSIS FOR THE DISRUPTIVE AND IMPULSE-CONTROL DISORDERS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT APPROACH

EPIDEMIOLOGY

ETIOLOGY

19. Personality Disorders

THE CLINICAL PRESENTATION

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

COMORBIDITY

COURSE AND PROGNOSIS

TREATMENT APPROACH

EPIDEMIOLOGY

ETIOLOGY

20. Other Conditions that May be a Focus of Clinical Attention

INTRODUCTION

MALINGERING

BEREAVEMENT

OCCUPATIONAL PROBLEMS

ADULT ANTISOCIAL BEHAVIOR

RELIGIOUS OR SPIRITUAL PROBLEM

ACCULTURATION PROBLEM

PHASE OF LIFE PROBLEM

NONCOMPLIANCE WITH TREATMENT

RELATIONAL PROBLEMS

B Treatment Across the Lifespan

21. Psychopharmacology

DRUG SELECTION

DRUG FACTORS

SIDE EFFECTS

PATIENT-RELATED FACTORS

INFORMED CONSENT AND PATIENT EDUCATION

DOSING, DURATION, AND MONITORING

LABORATORY TESTS AND THERAPEUTIC BLOOD MONITORING

TREATMENT OUTCOMES

COMBINATION OF DRUGS

COMBINED PSYCHOTHERAPY AND PHARMACOTHERAPY

SPECIAL POPULATIONS

REGULATORY ISSUES

NONAPPROVED DOSAGES AND USES

PLACEBOS

21.1 Antipsychotics

SEROTONIN–DOPAMINE ANTAGONISTS AND SIMILARLY ACTING DRUGS (SECOND-GENERATION OR ATYPICAL ANTIPSYCHOTICS)

DOPAMINE RECEPTOR ANTAGONISTS (FIRST-GENERATION ANTIPSYCHOTICS)

21.2 Antidepressants

SELECTIVE SEROTONIN REUPTAKE INHIBITORS

SELECTIVE SEROTONIN–NOREPINEPHRINE REUPTAKE INHIBITORS

BUPROPION

MIRTAZAPINE

NEFAZODONE AND TRAZODONE

TRICYCLICS AND TETRACYCLICS

MONOAMINE OXIDASE INHIBITORS

THYROID HORMONES

NOVEL AGENTS

21.3 Mood Stabilizers

LITHIUM

VALPROATE

LAMOTRIGINE

CARBAMAZEPINE AND OXCARBAZEPINE

OTHER ANTICONVULSANTS

CALCIUM CHANNEL BLOCKERS

21.4 Anxiolytics

BENZODIAZEPINES AND DRUGS ACTING ON GABA RECEPTORS

BUSPIRONE

β-Adrenergic Receptor Antagonists

BARBITURATES AND SIMILARLY ACTING DRUGS

21.5 Drugs Used to Treat Sleep Disorders

NONBENZODIAZEPINE GABA AGONISTS

MELATONIN AGONISTS: RAMELTEON AND MELATONIN

PRAZOSIN

21.6 Stimulants

STIMULANT DRUGS AND ATOMOXETINE

ATOMOXETINE (STRATTERA)

21.7 Drugs Used to Treat Substance Use Disorders

OPIOID RECEPTOR AGONISTS

OPIOID RECEPTOR ANTAGONISTS: NALTREXONE, NALMEFENE, AND NALOXONE

DISULFIRAM AND ACAMPROSATE

CLONIDINE AND GUANFACINE

21.8 Drugs Used for Cognitive Enhancement

CHOLINESTERASE INHIBITORS

MEMANTINE

21.9 Drugs Used to Treat Sexual Disorders

PHOSPHODIESTERASE-5 INHIBITORS

YOHIMBINE

21.10 Drugs Used to Treat the Side Effects of Psychotropic Drugs

ANTICHOLINERGIC AGENTS

ANTIHISTAMINES

DOPAMINE RECEPTOR AGONISTS AND PRECURSORS

DRUGS TO TREAT PSYCHOTROPIC-INDUCED WEIGHT GAIN

21.11 Nutritional Supplements and Related

NUTRITIONAL SUPPLEMENTS AND MEDICAL FOODS

PHYTOMEDICINES

22. Other Somatic Therapies

ELECTROCONVULSIVE THERAPY

OTHER BRAIN STIMULATION METHODS

NEUROSURGICAL TREATMENTS AND DEEP BRAIN STIMULATION

23. Psychotherapy

PSYCHOANALYSIS AND PSYCHOANALYTIC PSYCHOTHERAPY

BRIEF PSYCHODYNAMIC PSYCHOTHERAPY

GROUP PSYCHOTHERAPY, COMBINED INDIVIDUAL AND GROUP PSYCHOTHERAPY, AND PSYCHODRAMA

FAMILY THERAPY AND COUPLES THERAPY

DIALECTICAL BEHAVIOR THERAPY

BIOFEEDBACK

COGNITIVE THERAPY

BEHAVIOR THERAPY

HYPNOSIS

INTERPERSONAL THERAPY

NARRATIVE PSYCHOTHERAPY

COMBINED PSYCHOTHERAPY AND PHARMACOTHERAPY

MENTALIZATION-BASED TREATMENT

PSYCHOEDUCATIONAL INTERVENTIONS

24. Psychiatric Rehabilitation and Other Interventions

PSYCHIATRIC REHABILITATION

GENETIC COUNSELING

25. Consultation to Other Disciplines

25.1 Consultation-Liaison Psychiatry

HISTORY

CURRENT TRENDS

EVALUATION PROCESS IN PSYCHOSOMATIC MEDICINE

TREATMENTS USED IN PSYCHOSOMATIC MEDICINE

PSYCHO-ONCOLOGY

25.2 Geriatric Psychiatry

PSYCHIATRIC PROBLEMS OF OLDER PERSONS

MENTAL DISORDERS OF OLD AGE

SUICIDE RISK

OTHER CONDITIONS OF OLD AGE

SPOUSAL BEREAVEMENT

PSYCHOPHARMACOLOGICAL TREATMENT OF GERIATRIC DISORDERS

PSYCHOTHERAPY FOR GERIATRIC PATIENTS

25.3 Psychiatric Emergencies

TREATMENT SETTINGS

EPIDEMIOLOGY

EVALUATION

SPECIFIC INTERVIEW SITUATIONS

TREATMENT OF EMERGENCIES

PSYCHIATRIC EMERGENCIES IN CHILDREN

26. Level of Care

INPATIENT ADMISSION

PARTIAL HOSPITAL TREATMENT

INTENSIVE OUTPATIENT TREATMENT

OUTPATIENT CARE

RESIDENTIAL CARE

C Other Issues Relevant to Psychiatry

27. Ethics and Professionalism

PROFESSIONAL CODES

BASIC ETHICAL PRINCIPLES

SPECIFIC ISSUES

28. Forensic and Legal Issues

MEDICAL MALPRACTICE

PRIVILEGE AND CONFIDENTIALITY

HIGH-RISK CLINICAL SITUATIONS

HOSPITALIZATION

RIGHT TO TREATMENT

RIGHT TO REFUSE TREATMENT

CIVIL RIGHTS OF PATIENTS

SECLUSION AND RESTRAINT

INFORMED CONSENT

CHILD CUSTODY

TESTAMENTARY AND CONTRACTUAL CAPACITY AND COMPETENCE

CRIMINAL LAW

OTHER AREAS OF FORENSIC PSYCHIATRY

29. End-of-Life Issues and Palliative Care

29.1 Death, Dying, and Bereavement

DEATH AND DYING

BEREAVEMENT, GRIEF, AND MOURNING

LIFE CYCLE PERSPECTIVES ABOUT BEREAVEMENT

29.2 Palliative Care

PREVALENCE

GENERAL TREATMENT PRINCIPLES

ANXIETY IN PATIENTS WITH ADVANCED DISEASE

DEPRESSION IN PATIENTS WITH ADVANCED DISEASE

CONFUSIONAL STATES IN PATIENTS WITH ADVANCED DISEASE

DISEASE-SPECIFIC CONSIDERATIONS

PATIENT–FAMILY UNIT

DECISION POINTS, ADVANCE DIRECTIVES, PROXIES, AND SURROGATES

CARING FOR THE DYING PATIENT

COMMUNICATION

TERMINAL CARE DECISIONS

CARING FOR THE FAMILY

PALLIATIVE CARE

PAIN MANAGEMENT

PALLIATION OF OTHER SYMPTOMS

HOSPICE CARE

NEONATAL AND INFANT END-OF-LIFE CARE

CHILD END-OF-LIFE CARE

SPIRITUAL ISSUES

ALTERNATIVE AND COMPLEMENTARY MEDICINE

29.3 Euthanasia and Physician-Assisted Suicide

EUTHANASIA

PHYSICIAN-ASSISTED SUICIDE

FUTURE DIRECTIONS

30. Community Psychiatry

INTRODUCTION

CONTEMPORARY PUBLIC AND COMMUNITY PSYCHIATRY

THE ROLE OF PUBLIC AND COMMUNITY PSYCHIATRY IN TWENTY-FIRST CENTURY HEALTH CARE

31. Global and Cultural Issues in Psychiatry

PREVALENCE AND BURDEN OF MENTAL DISORDERS WORLDWIDE

TREATMENT GAP AND PROJECTED POPULATION-LEVEL TREATMENT EFFECTIVENESS WORLDWIDE

RESOURCES FOR MENTAL HEALTH CARE WORLDWIDE

PRINCIPLES FOR MENTAL HEALTH PROGRAM DEVELOPMENT AND BARRIERS TO CHANGE WORLDWIDE

STIGMATIZING ATTITUDES TOWARD PEOPLE WITH MENTAL DISORDERS

RELATIONSHIPS BETWEEN MENTAL AND PHYSICAL DISEASES

ETHICAL ISSUES IN MENTAL HEALTH CARE

INTERNATIONAL ORGANIZATIONS ACTIVE IN THE MENTAL HEALTH FIELD

FUTURE PERSPECTIVES

Glossary of Terms Relating to Signs and Symptoms

Index

In addition to being chief of staff and senior vice president at Menninger, Robert J. Boland, MD, is executive vice chair of the Menninger Department of Psychiatry & Behavioral Sciences at Baylor College of Medicine (BCM) and the Brown Foundation Endowed Chair in Psychiatry at BCM. He is responsible for the clinical care, research and education provided at The Clinic.

Prior to coming to Menninger, he served as vice chair of education and director of the psychiatry residency program at Brigham and Women’s Hospital and as an associate professor of psychiatry at Harvard Medical School. Board certified in psychiatry with expertise in medical education, psychosomatic medicine and geriatric psychiatry, he is an alumnus of Georgetown University where he earned his undergraduate and medical degrees.

Prior to joining Brigham and Women’s Hospital, Dr. Boland had an 18-year tenure at the Alpert School of Medicine at Brown University, Providence, R.I. He developed a special interest in depression resulting from medical illness and, later participated in the National Institute of Mental Health-sponsored Collaborative Depression Study. That project remains one of the longest studies of depression to date, for which Dr. Boland has written widely on the influence of depression on medical illness.

For more than 30 years, he has been an active member of the American Psychiatric Association and its Council on Psychosomatic Medicine. In addition, Dr. Boland served as the chair for the Psychiatry Residency Review Committee for the Accreditation Council and is a former president of the American Association of Directors of Psychiatric Residency Training.

What makes us different?

• Instant Download

• Always Competitive Pricing

• 100% Privacy

• FREE Sample Available

• 24-7 LIVE Customer Support